VSV-IFNβ-NIS intratumoral (IT) injection: A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors

S. F. Powell; M. R. Patel; J. Merchan; J. Strauss; T. P. Cripe; M. O. Old; R. M. Diaz; M. Reckner; B. Brunton; N. Packiriswamy; D. Upreti; L. Suksanpaisan; R. Vandergaast; R. Khan; S. J. Russell; K. W. Peng; A. S. Bexon

doi:10.1093/annonc/mdy288.108

VSV-IFNβ-NIS intratumoral (IT) injection: A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors

S. F. Powell, M. R. Patel, J. Merchan, J. Strauss, T. P. Cripe, M. O. Old, R. M. Diaz, M. Reckner, B. Brunton, N. Packiriswamy, D. Upreti, L. Suksanpaisan, R. Vandergaast, R. Khan, S. J. Russell, K. W. Peng, A. S. Bexon

Molecular Medicine

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	viii439
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy288.108
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy288.108

Cite this

Powell, S. F., Patel, M. R., Merchan, J., Strauss, J., Cripe, T. P., Old, M. O., Diaz, R. M., Reckner, M., Brunton, B., Packiriswamy, N., Upreti, D., Suksanpaisan, L., Vandergaast, R., Khan, R., Russell, S. J., Peng, K. W., & Bexon, A. S. (2018). VSV-IFNβ-NIS intratumoral (IT) injection: A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii439. https://doi.org/10.1093/annonc/mdy288.108

VSV-IFNβ-NIS intratumoral (IT) injection: A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors. / Powell, S. F.; Patel, M. R.; Merchan, J. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii439.

Research output: Contribution to journal › Article › peer-review

Powell, SF, Patel, MR, Merchan, J, Strauss, J, Cripe, TP, Old, MO, Diaz, RM, Reckner, M, Brunton, B, Packiriswamy, N, Upreti, D, Suksanpaisan, L, Vandergaast, R, Khan, R, Russell, SJ , Peng, KW & Bexon, AS 2018, 'VSV-IFNβ-NIS intratumoral (IT) injection: A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii439. https://doi.org/10.1093/annonc/mdy288.108

Powell SF, Patel MR, Merchan J, Strauss J, Cripe TP, Old MO et al. VSV-IFNβ-NIS intratumoral (IT) injection: A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 1;29:viii439. doi: 10.1093/annonc/mdy288.108

Powell, S. F. ; Patel, M. R. ; Merchan, J. et al. / VSV-IFNβ-NIS intratumoral (IT) injection : A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors. In: Annals of oncology : official journal of the European Society for Medical Oncology. 2018 ; Vol. 29. pp. viii439.

@article{7eedf65b14ec44a5a16e0ae8c7c37530,

title = "VSV-IFNβ-NIS intratumoral (IT) injection: A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors",

author = "Powell, {S. F.} and Patel, {M. R.} and J. Merchan and J. Strauss and Cripe, {T. P.} and Old, {M. O.} and Diaz, {R. M.} and M. Reckner and B. Brunton and N. Packiriswamy and D. Upreti and L. Suksanpaisan and R. Vandergaast and R. Khan and Russell, {S. J.} and Peng, {K. W.} and Bexon, {A. S.}",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy288.108",

language = "English (US)",

volume = "29",

pages = "viii439",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - VSV-IFNβ-NIS intratumoral (IT) injection

T2 - A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors

AU - Powell, S. F.

AU - Patel, M. R.

AU - Merchan, J.

AU - Strauss, J.

AU - Cripe, T. P.

AU - Old, M. O.

AU - Diaz, R. M.

AU - Reckner, M.

AU - Brunton, B.

AU - Packiriswamy, N.

AU - Upreti, D.

AU - Suksanpaisan, L.

AU - Vandergaast, R.

AU - Khan, R.

AU - Russell, S. J.

AU - Peng, K. W.

AU - Bexon, A. S.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081529630&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081529630&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy288.108

DO - 10.1093/annonc/mdy288.108

M3 - Article

C2 - 32137117

SN - 0923-7534

VL - 29

SP - viii439

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

VSV-IFNβ-NIS intratumoral (IT) injection: A first-in-human (FIH), phase I study of an innovative oncolytic virotherapy, alone and with an anti-PD-L1 antibody, in patients with refractory solid tumors

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this